Hot

Minimally Invasive Devices: Market Growth, Technologies, Use Cases, and Future Outlook

Posted on by admin5

Minimally invasive devices are at the center of a global shift from open surgery to less invasive, technology-enabled care that reduces pain, shortens hospital stays, and improves recovery. As healthcare systems push for value-based care and patients demand faster, safer treatment options, minimally invasive surgical devices, imaging systems, and robotic platforms have moved from niche tools to essential infrastructure in hospitals, ambulatory surgery centers, and specialized clinics.

What Are Minimally Invasive Devices and Why They Matter

Minimally invasive devices are tools, systems, and implants designed to diagnose or treat conditions through small incisions or natural orifices rather than large open cuts. They include laparoscopic devices, endoscopic systems, catheters, energy-based tools, interventional cardiology devices, neuromodulation implants, and robotic-assisted surgery platforms. Instead of exposing large areas of tissue, the physician or surgeon works through ports or access devices using cameras, miniature instruments, and advanced controls.

The core benefits of minimally invasive procedures are smaller incisions, less tissue trauma, reduced blood loss, lower infection risk, and faster functional recovery compared to traditional open surgery. Patients often experience less post-operative pain, need fewer opioids, and can return to work or daily activities sooner, which creates both clinical and economic advantages for providers, payers, and health systems. These benefits have led to a steady rise in minimally invasive surgery volumes in orthopedics, gynecology, cardiology, gastroenterology, urology, oncology, and spine surgery.

Global Market Trends for Minimally Invasive Devices

Across multiple industry reports, the minimally invasive surgery devices and minimally invasive surgical instruments markets are consistently projected to grow at high single-digit to low double-digit compound annual growth rates through 2030 and beyond. One forecast places the minimally invasive surgery devices market at over 35 billion dollars around 2025, with a path to more than 80 billion dollars by the mid-2030s as adoption accelerates in North America, Europe, and Asia-Pacific. Another assessment estimates minimally invasive surgical instruments alone at more than 38 billion dollars in 2025, with potential to surpass 100 billion dollars by 2035 as procedure volumes and case complexity rise.

North America currently holds the largest share of the minimally invasive devices market, driven by strong hospital infrastructure, favorable reimbursement, and high adoption of robotic-assisted surgery, laparoscopic devices, and interventional cardiology products. The United States minimally invasive surgery devices market is projected to surpass 10 billion dollars in 2025 and more than double by 2034 as chronic disease prevalence, aging populations, and preference for less invasive treatments continue to rise. Asia-Pacific is expected to register the fastest growth, supported by investments in hospital infrastructure, expanding private healthcare networks, and rising awareness of minimally invasive surgery among patients and clinicians.

Key demand drivers include growing incidence of cardiovascular disease, cancer, obesity, osteoarthritis, gastrointestinal disorders, and urologic conditions that benefit from minimally invasive interventions. At the same time, technological advances in imaging, navigation, energy delivery, robotics, and biomaterials are expanding the range of procedures that can be performed with minimal access. This combination of clinical need and device innovation underpins long-term market expansion for minimally invasive devices across subspecialties.

Core Categories of Minimally Invasive Devices

Minimally invasive devices span a wide array of technologies, but they can be grouped into several core categories that share similar clinical and technical requirements.

Laparoscopic and Endoscopic Devices

Laparoscopic instruments and endoscopic systems are among the most widely used minimally invasive devices. Laparoscopic tools include graspers, scissors, dissectors, needle holders, retractors, clip appliers, and endoscopic staplers designed for use through trocar ports in the abdomen or pelvis. These instruments often feature long shafts, ergonomic handles, and rotating or articulating tips to facilitate precise manipulation in confined spaces.

Endoscopic platforms combine flexible or rigid scopes, high-definition cameras, light sources, and working channels for instruments. Gastrointestinal endoscopes, colonoscopes, bronchoscopes, hysteroscopes, and cystoscopes allow diagnosis, biopsy, polypectomy, stent placement, and therapeutic interventions without large incisions. Continuous improvements in optics, illumination, and chip-on-tip camera technology have dramatically enhanced visualization quality, enabling earlier detection of lesions and safer tissue manipulation.

Access Devices: Trocars, Cannulas, and Catheters

Access devices make minimally invasive procedures possible by providing controlled entry to internal cavities or vessels. Trocars and cannulas create sealed ports through the abdominal wall for laparoscopic surgery, maintaining pneumoperitoneum and allowing repeated insertion and removal of instruments. Modern trocar designs focus on reducing insertion force, minimizing port-site complications, and offering compatibility with a wide range of devices.

Catheters are critical access tools in interventional cardiology, interventional radiology, endovascular surgery, and neurovascular procedures. Balloon catheters, guiding catheters, microcatheters, and delivery systems facilitate stent placement, embolization, angioplasty, thrombectomy, ablation, and targeted drug delivery via small punctures in the skin, often in the groin or wrist. These minimally invasive catheter-based devices have reduced the need for open vascular and cardiac surgery in many cases.

Energy-Based and Electrosurgical Devices

Energy-based devices are a core component of modern minimally invasive surgery. Electrosurgical units deliver radiofrequency energy for cutting and coagulating tissue, often through laparoscopic or endoscopic instruments. Advanced bipolar and ultrasonic energy systems allow precise vessel sealing and dissection with minimal thermal spread, improving hemostasis and reducing collateral tissue damage.

Laser systems, radiofrequency ablation probes, cryoablation catheters, and microwave ablation devices are used in interventional oncology, cardiology, and pain management for tumor ablation, arrhythmia treatment, and nerve ablation. Integration of energy delivery with real-time imaging and navigation has improved accuracy and safety of these minimally invasive interventions, enabling treatment of lesions that previously required open surgery.

Robotic-Assisted Surgery Systems

Robotic minimally invasive devices represent some of the most sophisticated platforms in the operating room. Robotic-assisted surgical systems offer magnified 3D visualization, motion scaling, tremor filtration, and articulated instruments that mimic or exceed the dexterity of the human wrist. These devices have gained traction in urologic surgery, gynecology, general surgery, thoracic surgery, colorectal surgery, and increasingly in spine and joint procedures.

Also check:  Reusable Medical Instruments: Market Growth, Safety Standards, and Smart Investment Strategies

Recent approvals of new robotic platforms from multiple manufacturers, including systems for transvaginal hysterectomy and other specialized procedures, are intensifying competition and expanding use cases. Hospitals adopt robotic minimally invasive devices to attract surgeons and patients, differentiate their surgical services, and potentially improve outcomes such as reduced complications, shorter length of stay, and more precise tissue handling.

Implants and Interventional Devices

Many minimally invasive procedures rely on implants and interventional devices that remain in the body. In cardiology, these include coronary and peripheral stents, transcatheter heart valves, occluder devices, and left atrial appendage closure systems delivered through catheters. In orthopedics and spine surgery, minimally invasive screws, rods, cages, and interbody devices are inserted through small incisions or percutaneous approaches, aided by navigation and fluoroscopy.

Neuromodulation devices such as spinal cord stimulators and deep brain stimulation systems are implanted through minimally invasive approaches to treat chronic pain and movement disorders. Urology and women’s health also leverage minimally invasive implants for stress urinary incontinence, pelvic organ prolapse, fertility management, and long-acting contraception. These device categories benefit directly from improvements in delivery systems, imaging, and miniaturization.

Top Minimally Invasive Devices and Use Cases

The minimally invasive space spans hundreds of product lines, but several device categories stand out due to their high procedure volumes and clinical impact.

Device / Category Key Advantages Typical Rating Perception Common Use Cases
Laparoscopic staplers and energy devices Secure tissue closure, fast vessel sealing, reduced blood loss Very high among surgeons for reliability and efficiency Bariatric surgery, colorectal resection, gastric procedures, lung wedge resection
High-definition endoscopy systems Enhanced visualization, early lesion detection, improved ergonomics High due to image quality and workflow integration Upper GI endoscopy, colonoscopy, ERCP, bronchoscopic procedures
Robotic-assisted surgery platforms 3D vision, wristed instruments, improved ergonomics and precision High in centers of excellence; growing acceptance globally Prostatectomy, hysterectomy, hernia repair, colorectal surgery, thoracic surgery
Interventional cardiology catheters and stents Percutaneous access, shorter recovery, lower acute risk versus open surgery Very high, especially for complex coronary and structural heart disease Coronary angioplasty, stent placement, transcatheter valve procedures
Minimally invasive spine systems Smaller incisions, less muscle disruption, faster recovery Increasingly positive as techniques and implants mature Lumbar fusion, decompression, vertebral augmentation
Neuromodulation implants Targeted therapy, reduced systemic medications, adjustable over time Strong in chronic pain and movement disorder management Chronic back pain, neuropathic pain, Parkinson’s disease symptom control

These categories reflect core purchasing decisions for hospitals and ambulatory surgery centers seeking to expand minimally invasive service lines. Device selection often balances ease of use, consistency of performance, training requirements, procedural time, and total cost of ownership, including disposable components and service contracts.

Competitive Landscape and Comparison Matrix

The competitive landscape for minimally invasive devices is diverse, with large multinational manufacturers, focused specialty companies, and innovative startups all playing roles. Established players dominate high-volume categories such as laparoscopic instruments, staplers, electrosurgical units, and interventional cardiology devices, while newer companies frequently enter high-growth segments like robotics, navigation, and niche implant systems.

Dimension Traditional Open Surgery Equipment Standard Minimally Invasive Devices Advanced Robotic and Image-Guided Systems
Incision size Large, multi-centimeter incisions Small ports, punctures, or natural orifice access Similar small access, sometimes fewer ports
Recovery time Longer hospital stay, extended rehab Shorter hospital stay, faster return to normal activities Comparable or slightly improved versus standard MIS in some procedures
Capital cost Lower device cost but higher indirect costs Moderate device and disposable cost High initial capital and service costs
Training requirements Widely established skill sets Requires specific training and credentialing Intensive training, proctoring, and learning curve
Imaging and visualization Direct line of sight, sometimes limited field 2D or 3D video, enhanced magnification 3D HD, integrated imaging, sometimes augmented reality
Precision and ergonomics Dependent on surgeon skill and exposure Good precision, some ergonomic challenges High precision, improved ergonomics, motion scaling

Hospitals evaluate minimally invasive device portfolios based on clinical outcomes, reliability, vendor support, and long-term cost profiles rather than individual device price alone. Vendors that combine strong device performance with comprehensive service, training, and data analytics are often better positioned to win tenders and long-term contracts.

Technology Drivers in Minimally Invasive Devices

Several technological trends are reshaping how minimally invasive devices are designed, manufactured, and used in daily practice.

One major driver is improved visualization. High-definition and ultra-high-definition imaging, 3D displays, chip-on-tip endoscopes, and fluorescence imaging enable surgeons to see vascular structures, lymphatics, and tumors more clearly. Advanced optics and digital enhancement reduce fogging and improve depth perception, which is critical for complex procedures in confined spaces.

Another key driver is integration of robotics and computer-assisted systems into minimally invasive workflows. Robotic platforms increasingly incorporate machine vision, haptic feedback, and automation of routine steps. Image-guided systems use preoperative CT or MRI combined with intraoperative fluoroscopy or cone-beam CT to guide implants and instruments with submillimeter accuracy in spine, orthopedics, neurosurgery, and interventional oncology.

Miniaturization and advanced materials have also expanded minimally invasive device options. Smaller-diameter catheters, thinner-walled access sheaths, and low-profile implants allow treatment of smaller vessels and more fragile anatomy with less trauma. New polymers, nitinol alloys, and bioresorbable materials support stent designs, embolic agents, and implantable devices tailored to specific pathologies while maintaining flexibility and durability.

Digital connectivity is rapidly becoming a differentiator. Many modern minimally invasive devices and platforms collect procedural data, track utilization, and integrate with hospital information systems. Connectivity enables remote proctoring, tele-mentoring, predictive maintenance, and data-driven optimization of instrument sets and operating room workflows.

Real-World Use Cases and ROI of Minimally Invasive Devices

Hospitals and health systems evaluate minimally invasive devices not only on clinical performance but also on return on investment across an entire episode of care. When minimally invasive devices reduce length of stay, complications, and readmissions, they support value-based reimbursement models and capacity expansion without building new facilities.

Also check:  Diagnostic Devices: Global Market Trends, Technologies, and Buying Guide for 2026

A typical example is laparoscopic cholecystectomy compared with open gallbladder surgery. Minimally invasive technique using laparoscopic instruments and energy devices usually allows discharge within one day and quicker return to daily activities, whereas open surgery often requires longer hospitalization and recovery. The hospital may see higher device and OR costs per case but gains capacity, improved patient satisfaction scores, and lower complication-related expenses.

In orthopedic and spine surgery, minimally invasive devices that support percutaneous pedicle screw placement, tubular retractors, and endoscopic decompression have shown benefits in reduced blood loss, shorter stays, and faster functional recovery in appropriately selected patients. While imaging and navigation requirements may raise procedural costs, payers and providers often value reduced need for post-acute care facilities and quicker return to work.

In cardiology, catheter-based minimally invasive devices for coronary interventions and structural heart disease have transformed how many patients are treated. Transcatheter aortic valve replacement, using specialized delivery catheters and valve systems, offers elderly or high-risk patients an alternative to open-heart surgery. Although device costs are high, shorter intensive care stays, reduced surgical trauma, and improved quality of life in responders support adoption in carefully defined populations.

Quantifying ROI typically involves analyzing direct costs, length of stay, readmission rates, complication rates, and long-term outcomes. Institutions that standardize minimally invasive pathways, invest in training, and optimize case selection tend to realize the greatest economic benefits from minimally invasive devices.

Company Background Highlight: ALLWILL’s Role in Medical Aesthetic Devices

Within the broader minimally invasive ecosystem, medical aesthetics is a fast-growing segment that increasingly uses energy-based devices, lasers, and minimally invasive technologies for skin tightening, body contouring, hair removal, and scar revision. ALLWILL is redefining B2B medical aesthetics by focusing on innovation, trust, and efficiency, with a mission to solve the challenges practitioners face when sourcing, maintaining, and upgrading medical equipment rather than simply selling devices. Through its Smart Center for inspection, repair, and refurbishment, vendor management system MET, and Lasermatch inventory platform, ALLWILL enables clinics to access new and refurbished aesthetic devices, training, and service solutions that support sustainable growth and consistent patient results.

Regulatory Environment and Compliance Considerations

Minimally invasive devices must meet stringent regulatory requirements in major markets such as the United States, European Union, and Asia-Pacific. In the United States, devices are cleared or approved by the Food and Drug Administration through pathways such as 510(k) clearance for devices substantially equivalent to existing products or premarket approval for higher-risk innovations. Manufacturers must adhere to quality system regulations, good manufacturing practices, and post-market surveillance requirements.

In Europe, the Medical Device Regulation has increased scrutiny on clinical evidence, post-market follow-up, and supply chain transparency for minimally invasive devices. Companies must provide robust data on safety and performance, maintain updated technical documentation, and work with notified bodies to maintain CE marking. Similar regulatory frameworks exist in other regions, with growing emphasis on unique device identifiers, real-world evidence, and long-term patient safety.

Hospitals and providers also face responsibilities in tracking device performance, reporting adverse events, and ensuring that minimally invasive devices are used by appropriately trained clinicians. Credentialing, proctoring, and ongoing education programs are essential to maintain high standards of care when introducing complex new technologies such as robotic platforms and novel energy devices.

Procurement, Service, and Lifecycle Management

Effective management of minimally invasive devices goes beyond initial purchase. Hospitals and clinics must consider maintenance, calibration, spare parts, software updates, and end-of-life strategies for device replacement or refurbishment. Total cost of ownership over five to ten years can significantly exceed initial acquisition cost, especially for capital-intensive platforms.

Many providers negotiate service contracts that include preventive maintenance, uptime guarantees, and access to loaner devices. Some adopt managed equipment services, where vendors take on responsibility for supplying and maintaining a fleet of minimally invasive devices under long-term agreements. Refurbished devices can offer a cost-effective option for facilities with budget constraints, provided they are restored under rigorous quality standards and supported with warranties and training.

Digital tools for inventory management, utilization tracking, and predictive maintenance are increasingly important. By monitoring usage patterns and performance metrics across endoscopy towers, laparoscopic instrument sets, camera systems, and robotic platforms, organizations can rationalize their fleets, reduce instrument loss, and optimize tray configurations to minimize reprocessing bottlenecks.

Emerging Innovations in Minimally Invasive Devices

Several emerging technologies are poised to redefine what minimally invasive devices can do in the next decade. One area is flexible robotics, where soft, steerable robotic endoscopes and catheters with embedded sensors can navigate complex anatomy more safely and intuitively. These devices may enable minimally invasive access to previously hard-to-reach regions of the lung, brain, or peripheral vasculature.

Another area is augmented reality and mixed reality integration. Surgeons and interventionalists can overlay preoperative imaging, anatomical maps, or navigation cues onto their field of view during minimally invasive procedures. When combined with instrument tracking and intraoperative imaging, this technology can improve accuracy and confidence in tumor margins, pedicle screw placement, and complex reconstructions.

Artificial intelligence and machine learning are also entering the minimally invasive arena. Algorithms can assist in real-time image interpretation, instrument recognition, and workflow guidance. For example, AI tools may highlight suspicious lesions during colonoscopy or suggest optimal viewing angles during endoscopic procedures. Over time, AI could help standardize technique, reduce variability between surgeons, and shorten learning curves for new minimally invasive devices.

Additionally, new biomaterials and drug-device combinations are enabling minimally invasive local therapies that release medications directly at the treatment site. Drug-eluting stents, localized immunotherapy delivery devices, and biodegradable implants are examples of how pharmacology and device design intersect to improve outcomes with minimal systemic exposure.

Also check:  Certified Pre-Owned Devices: The Complete Guide To Value, Safety, And Performance

Challenges and Barriers to Adoption

Despite strong momentum, several challenges can slow adoption of minimally invasive devices. High capital costs for robotic systems, advanced imaging, and navigation platforms can be a barrier for smaller hospitals or clinics, especially in regions with constrained reimbursement. Even in larger centers, competing demands for capital—from imaging to IT to infrastructure—can delay investment in new minimally invasive technology.

Training and learning curves are another significant issue. Surgeons, interventionalists, nurses, and technologists must adapt to new devices, instrumentation, and workflows. This requires time away from clinical duties, access to simulation and proctored cases, and ongoing opportunities to maintain proficiency. Institutions that lack structured training programs may see higher complication rates or longer procedure times initially, which can discourage use.

There are also concerns about overuse or inappropriate indications as technology becomes more widely available. When minimally invasive devices are applied to patients who would be better served by alternative treatments, outcomes can suffer and costs can rise. Evidence-based guidelines, multidisciplinary decision-making, and robust outcomes tracking are essential to ensure that minimally invasive approaches are used in the right patients at the right time.

Finally, supply chain resilience and sterilization capacity can limit deployment of complex minimally invasive device sets. Hospitals must ensure ready availability of sterile instruments and single-use components to support growing procedure volumes. Disruptions in supply or reprocessing workflows may force cancellations or reversion to open techniques in some cases.

Future Trends and Market Outlook

Looking ahead to 2030 and beyond, minimally invasive devices are expected to penetrate even more deeply into routine and complex care pathways. Robotic-assisted surgery, once limited to high-profile specialties, will likely become more modular, cost-effective, and procedure-specific, enabling broader adoption across mid-sized hospitals and ambulatory surgery centers. Multi-port and single-port systems, as well as robotic endoscopy platforms, will diversify the robotic market.

In parallel, more procedures will shift from inpatient to outpatient settings due to improvements in device design, anesthesia protocols, and perioperative care. Ambulatory surgery centers and office-based labs will increasingly perform minimally invasive procedures in orthopedics, pain management, vascular disease, and aesthetics, using compact, versatile devices optimized for smaller environments.

Global expansion will be a defining trend. Emerging markets in Asia, Latin America, Eastern Europe, and the Middle East are investing in hospital infrastructure and training to provide advanced minimally invasive procedures locally. Manufacturers that can offer robust devices tailored to varying resource environments, along with training and service, will capture new growth.

Environmental sustainability will influence device design and supply chains. Hospitals are under pressure to reduce medical waste and carbon footprints. This may drive interest in reposable or reusable minimally invasive devices with validated reprocessing protocols, modular components, and reduced packaging. Manufacturers will need to balance sustainability with infection control, regulatory requirements, and economic considerations.

Practical FAQs on Minimally Invasive Devices

What makes a procedure minimally invasive compared to open surgery?
A procedure is considered minimally invasive when it uses small incisions, ports, or natural orifice access rather than large open cuts, usually assisted by cameras and specialized instruments. This approach aims to minimize tissue trauma while achieving the same or better therapeutic effect as open surgery.

Which surgical specialties rely most on minimally invasive devices today?
The leading specialties include general surgery, gynecology, urology, cardiology, gastroenterology, orthopedics, spine surgery, thoracic surgery, neurosurgery, and interventional radiology, with expanding use in oncology and otolaryngology as devices and techniques evolve.

Are minimally invasive devices always safer than traditional tools?
Minimally invasive devices can reduce infection risk, blood loss, and recovery time, but safety depends heavily on patient selection, operator experience, and appropriate use. In some complex or emergency cases, open surgery remains the safer option.

How do hospitals justify the cost of advanced minimally invasive platforms?
Hospitals evaluate overall value, including shorter length of stay, fewer complications, reduced readmissions, higher patient and surgeon satisfaction, and the ability to attract referrals, in addition to direct procedure costs and device pricing.

What training is required to use minimally invasive devices effectively?
Training typically includes didactic education, simulation, hands-on labs, mentorship by experienced operators, and proctored clinical cases. Credentialing committees often set minimum case volume and competency benchmarks before independent use.

Can patients request minimally invasive options for their procedures?
Patients can discuss minimally invasive options with their surgeons or specialists, asking whether a laparoscopic, endoscopic, catheter-based, or robotic approach is appropriate for their condition. The final decision depends on clinical factors, anatomy, co-morbidities, and available expertise.

Conversion-Focused Next Steps for Stakeholders

Healthcare leaders, surgeons, and device decision-makers who want to capitalize on the growth in minimally invasive devices should begin by assessing current service lines and identifying procedures where conversion from open to minimally invasive approaches would deliver the greatest clinical and economic benefit. Mapping existing volumes, complication rates, and length of stay data helps prioritize where investments in training, devices, and workflow redesign will yield the highest impact.

Technology and procurement teams can then work together to define requirements for minimally invasive platforms, including imaging, energy systems, access devices, robotic or navigation capabilities, and service coverage. Partnering with vendors that can provide training, data analytics, and lifecycle support makes it easier to scale minimally invasive programs sustainably and align them with organizational strategy.

For clinicians, now is the time to build or refine minimally invasive skills, participate in multidisciplinary pathways, and engage in outcomes tracking to demonstrate the value of these techniques. By combining evidence-based patient selection with advanced minimally invasive devices, providers can accelerate recovery, enhance patient experience, and strengthen the competitive position of their institutions in a rapidly evolving healthcare landscape.

admin5

联系我们|Contact Form

TERMS AND CONDITIONS 

These Terms and Conditions (these “Terms”), together with the attached or accompanying quote page (the “Quote,” collectively, this “Agreement”), exclusively govern the sale by Healthcare Markets, Inc., a Delaware corporation doing business as “Powered by MRP” (“MRP”), and the purchase and use by the buyer set forth on the Quote (“Buyer”), of the equipment (the“Equipment”) and/or services (the “Services”).

        1.  EQUIPMENT AVAILABILITY. Equipment offered for sale by MRP is subject to availability. MRP shall not be liable to Buyer in case of stock outage or unavailability of the Equipment. MRP reserves the right to change the equipment offered for sale at any time and without notice to Buyer. Availability of equipment may be determined when an order is placed, and, if unavailable, MRP will inform Buyer of such unavailability, offer other available equipment as substitution or cancel the order. Such cancelled order will be refunded by MRP to Buyer, except for an order for a Special Order Product, which cannot be cancelled once the order is placed.

        2.  PRICES. Written price quotations on the Quote shall last for ten (10) days from the date issued and then automatically expire, and quoted prices do not include taxes, freight, handling, duty, insurance or other similar charges, which Buyer must pay unless waived in writing by MRP or a valid tax exemption certificate is provided to MRP. Notwithstanding the foregoing, all published prices may be changed by MRP at any time without notice to Buyer.

        3.  TERMS OF PAYMENT. Unless otherwise agreed to on the Quote or in writing by MRP, prepayment in full is required, by bank transfer, cash, credit card or certified check, and where partial pre-payment is permitted, such payment shall be nonrefundable with the balance due net thirty (30) days from the date of invoice. MRP reserves the right to modify or revoke any credit previously extended. Past due balances shall be subject to a service charge of one and one-half percent (1.5%) per month, not to exceed the maximum amount permitted by applicable law. Buyer agrees to pay all fees, charges or other sums payable hereunder, including collection fees incurred, with no right of set-off or reduction of any nature unless approved in writing by an MRP corporate officer (an “MRP Officer”). Buyer hereby grants, and MRP reserves, a purchase money security interest in the Equipment purchased, and in any proceeds thereof, to secure Buyer’s payment obligations hereunder. Buyer shall cooperate fully with MRP to execute such documents and accomplish such filings and/or recordings as MRP may deem necessary for the protection of its interests in the Equipment furnished to Buyer, and in the event Buyer does not aid within a reasonable time after MRP asks Buyer to do so, Buyer hereby authorizes and appoints MRP as Buyer’s attorney-in-fact to execute, deliver and file at any time, any financing statement and/or take any other action permitted by applicable law to perfect, enforce, continue and amend MRP’s security interest in any jurisdiction deemed appropriate by MRP. Buyer agrees that upon nonpayment of any charges due to MRP, MRP may cancel or delay delivery of the Equipment and/or suspend any applicable service coverage, which may resume only when MRP receives payment in full, and the warranty period will continue to run during such time of nonpayment although warranty service will not be available.

        4.  SHIPMENT AND DELIVERY. Delivery dates are estimated, and partial deliveries are allowed. MRP shall not be liable for or in respect of any loss or damage arising from any delay in filling any order, failure to deliver or delay in delivery. No delay in the shipment or delivery of any Equipment relieves Buyer of its obligations under this Agreement, including, without limitation, accepting delivery of any remaining installment(s) of the Equipment, if applicable. Buyer must pay for, and hold MRP harmless from, all shipping, delivery, and insurance expenses unless otherwise agreed in writing by an MRP Officer or otherwise indicated on the Quote. MRP will not assume any liability if MRP selects the shipping methods nor will any carrier be deemed to be MRP’s agent. “Time is of the essence” terms will not apply to orders accepted by MRP. Title and risk of loss of the Equipment shall pass to Buyer, and delivery shall be deemed completed, when the Equipment is delivered to Buyer’s address. Should loss or damage in transit occur, Buyer’s payment obligations will not be affected. Buyer is liable for all costs for MRP’s holding or storing of the Equipment if delivery is delayed by Buyer or at Buyer’s request. If delivery is delayed over thirty (30) days, MRP may, at its option and upon notice to Buyer, cancel that and all future deliveries without further liability or obligation of any kind.

        5.  FORCE MAJEURE. MRP shall not be responsible for delays or failure to render or service any Equipment and/or perform any Service due to any cause beyond MRP’s control, including, but not limited to: (a) acts of God; (b) flood, fire, earthquake, epidemic, pandemic or explosion; (c) war, invasion, hostilities (whether war is declared or not), terrorist threats or act, riot or other civil unrest; (d) government order, law or actions; (e) embargoes or blockades in effect on or after the date of this Agreement; (f) national or regional emergency; (g) strikes, labor stoppages or slowdowns or other industrial disturbances; and (h) telecommunication breakdowns, power outages or shortages, lack of warehouse or storage space, inadequate transportation services or inability or delay in obtaining supplies of adequate or suitable material (each, a “Force Majeure Event”). Any delivery date may be extended, at MRP’s sole discretion, to the extent of any delay resulting from any Force Majeure Event.

        6.  ACCEPTANCE; INSPECTION. Except for Special Order Products, Buyer shall inspect all Equipment upon delivery and within forty-eight (48) hours of delivery to Buyer shall give written notice to MRP of any error or claim that any Equipment does not conform to the terms of this Agreement; any claims not made within such period shall be deemed waived and released, with the Equipment being accepted by Buyer. Except as provided under this Section 6 and Section 7 hereof, all sales of Equipment to Buyer are made on a one-way basis, and Buyer has no right to return Equipment purchased under this Agreement to MRP. Subject to the warranty set forth in Section 8(c)(iv), Services are deemed to be accepted by Buyer upon completion of their performance by MRP.

        7.  CANCELLATION CHARGES AND RETURNED EQUIPMENT POLICY. Returns and cancellations are not permitted without written approval by an MRP Officer, which shall be made in such MRP Officer’s sole discretion. If approved, MRP will issue a return merchandise authorization number, which Buyer must include in the returned packaging, and Buyer must pay MRP either a (a) twenty percent (20%) restocking charge on the purchase price of the item if Buyer’s written request for return or cancellation is received by MRP’s headquarters after MRP’s original shipment of the Equipment or (b) a ten percent (10%) cancellation damages charge if Buyer’s request was received before said shipment. The foregoing charges are agreed upon, not as a penalty, but because of the difficulty of computing actual damages, and until the applicable charge is paid and the Equipment has been received back by MRP in new condition, no refund will be given. This document or copies hereof may be filed with the appropriate authorities as a financing statement to pursue such charges. In no case will shipping and freight costs be refunded. Removed, replaced or substituted equipment and parts (collectively, “Returned Equipment”) shall become MRP’s property, with title and ownership transferring to MRP upon the earlier of its return or replacement, with MRP owing no other obligations on the Returned Equipment. Buyer hereby agrees to indemnify, defend and hold harmless MRP Indemnitees from any claims, costs, losses, attorneys’ fees and expenses related to any third-party attempts to claim ownership of the Returned Equipment or dispute any trade-in, removal, substitution or replacement, and the remaining provisions shall continue in full force and effect.

        8.  MRP’S WARRANTIES, IF ANY.

(a) Equipment Sold “As Is.” UNLESS OTHERWISE STATED ON THE QUOTE OR IN A WRITING SIGNED BY AN MRP OFFICER, BUYER AGREES THAT THE EQUIPMENT SOLD IN THIS AGREEMENT IS BEING SOLD ON AN “AS IS,” “AS AVAILABLE” BASIS, SUBJECT TO SECTIONS 8(c) AND 9, AND HAVE NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, WHETHER IMPLIED OR ARISING BY LAW, STATUTE OR OTHERWISE, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR USE, NON-INFRINGEMENT, WORKMANLIKE MANNER, QUALITY, ACCURACY, TITLE, AND/OR IMPLIED FROM A COURSE OF DEALING OR PERFORMANCE USAGE IN TRADE.

(b) Special Order Product. If this Agreement includes the sale of a product that MRP does not currently have or typically keep in stock, in MRP’s sole determination, but is acquired from a third party specifically for Buyer (a “Special Order Product”), then Buyer agrees that (i) Buyer, at its sole discretion, has made the selection of such Special Order Product, (ii) such Special Order Product is being acquired by MRP solely at the request of Buyer, (iii) no representation, warranty or guarantee has been made by MRP with respect to such Special Order Product, (iv) the obligation of Buyer to pay MRP for the Special Order Product is absolute and unconditional, and (v) Buyer waives and releases MRP from all claims, damages and losses arising out of such Special Order Product. Special Order Products carry no right to inspection before or after delivery, and MRP is not responsible for examining or evaluating such Special Order Products. MRP makes no warranty about Special Order Products and offerings of the third party (including description of the Special Order Product). MRP does not assume any responsibility or liability for the actions, product and content of all these and any other third parties. If there are any problems with any Special Order Product, Buyer must contact the manufacturer of such Special Order Product for assistance.

(c) Limited Warranties, If Any.

(i) If the Quote expressly states that the Equipment has a warranty for a certain time (a “Warranty Period”), then MRP warrants that the Equipment shall be in good working order under normal use for the Warranty Period, which Warranty Period shall commence from the date of delivery to Buyer (the “Delivery Date”), unless otherwise approved by an MRP Officer in writing, except for the following: (A) New (not used or pre-owned) Equipment that is to be serviced by MRP: if the Quote is silent, warranted to be in good working order under normal use for one hundred eighty (180) days from the Delivery Date; (B) Used Equipment sold refurbished by MRP: if the Quote is silent, warranted to be in good working order under normal use for thirty (30) days from the Delivery Date; (C) Consumable/disposable Equipment: if the Quote is silent, warranted to have been shipped from MRP in functional condition, and no additional warranty shall apply; no service shall be provided either. These items should be inspected for obvious damage, subject to Section 6 and 8(e), and MRP’s obligation under this warranty and this Section 8(c)(i)(C) is limited to replacement of the Equipment; and (D) New (not used or pre-owned) Equipment that is to be serviced by the manufacturer: if the Quote is silent, MRP makes no warranty for any such Equipment. Buyer’s sole warranty for any such Equipment, if any, shall be the original manufacturer’s warranty, which MRP agrees to pass on to Buyer, as applicable. (ii) For the limited warranties of Section 8(c)(i), including exceptions (A) and (B), but not (C) or this (D), Buyer is entitled to telephone, e-mail and video technical assistance and, subject to Sections 8(d) and 8(e), repair or replacement of such Equipment, in MRP’s sole discretion, should the Equipment become inoperative through normal use during the Warranty Period. Loaner equipment is not provided, but if so arranged by MRP, Buyer shall pay MRP the cash list price of any unreturned loaner equipment provided by MRP within seven (7) days of a written demand from MRP. (iii) Repair or replacement under any limited warranty of Equipment may be with parts or products that are new, used or refurbished, carrying the same limited warranty for the remaining term of the original item. Repairs or replacements shall not interrupt, extend or prolong the term of the warranty. (iv) For Services purchased under this Agreement, MRP warrants that the Services shall be performed using competent personnel in a professional manner in accordance with generally recognized industry standards for similar services. Subject to Sections 6 and 8(e) herein, if any Service was not performed in accordance with the aforementioned warranty, then MRP shall, in its sole discretion, either (A) repair or re-perform the applicable Service, or (B) credit or refund the price of such Service at the pro rata contract rate.

(d) Exclusions. MRP reserves the right, without liability, to void all warranties and remedies, including any obligation to service, repair, replace or otherwise remedy defects, errors or failures of the Equipment due to the occurrence of any of these events, and MRP shall be in no way responsible for: (i) handling, maintenance or use in a manner that is inconsistent with and/or contrary to the original manufacturer’s or MRP’s recommended procedures and/or instructions, including, without limitation, use of or with an unauthorized third-party good or part; (ii) any failure or damage resulting from negligence, alteration, modification or relocation of the Equipment by Buyer, its employees, agents or representatives; (iii) attempted or actual unauthorized dismantling, disassembling, service, repair, addition or change of the Equipment, including, without limitation, changing the serial number or shot count; (iv) abnormal wear and tear, including, without limitation, use under abnormal conditions (e.g., unclean, dusty, or exposure to extreme electromagnetic radiation, temperature or humidity); or (v) damage or failure of the Equipment due to a Force Majeure Event or a problem in the premises of the Equipment. In any of the above situations, or for any Equipment that has no warranty, MRP has sole discretion to service the Equipment, at Buyer’s expense, at MRP’s then-in-effect rates for service, labor, travel, shipping and materials.

(e) Notice and Inspection. The limited warranties contained in this Section 8 are made on condition that immediate written notice of any noncompliance with the Equipment’s and/or the Service’s warranty be given to MRP, and provided that MRP’s inspection reveals that Buyer’s claim is valid under the terms of such warranty.

        9.  DISCLAIMERS; NO OTHER WARRANTY. EXCEPT TO THE EXTENT AS PROVIDED IN SECTION 8(c)(i)(D), BUYER ACKNOWLEDGES THAT MRP IS NOT BOUND BY ANY WARRANTY THAT MAY BE SET FORTH IN A MANUFACTURER’S WRITTEN MATERIALS THAT WOULD HAVE APPLIED HAD BUYER PURCHASED THE EQUIPMENT DIRECTLY FROM THE MANUFACTURER IN ITS UNUSED STATE. BUYER ACKNOWLEDGES THAT BUYER HAS NOT RELIED UPON ANY WARRANTY OTHER THAN AS SET FORTH IN THIS AGREEMENT. IN ADDITION, BUYER ALSO HEREBY ACKNOWLEDGES AND AGREES THAT ANY ORAL OR WRITTEN STATEMENTS CONCERNING USE AND REGULATION OF MEDICAL DEVICES SOLD BY MRP ARE AND SHALL BE CONSTRUED AS FOR INFORMATIONAL PURPOSES ONLY AND WITHOUT WARRANTY OR ASSURANCE BY MRP AS TO THEIR ACCURACY OR VALIDITY. MRP ALSO HEREBY DISCLAIMS ANY AND ALL WARRANTIES REGARDING OTHER MEDICAL CARE OR HELP, INCLUDING THE SELECTION OF AESTHETIC AND MEDICAL PROCEDURES AND PRODUCTS FOR, OR CARE OF, PATIENTS. THE LIMITED WARRANTIES OF THIS AGREEMENT, IF APPLICABLE TO ANY EQUIPMENT OR SERVICE FURNISHED UNDER THIS AGREEMENT, CONSTITUTE THE ONLY WARRANTIES MADE WITH RESPECT TO THE EQUIPMENT AND/OR SERVICE AND ANY DEFECT, DEFICIENCY OR NONCONFORMITY. TO THE EXTENT PERMITTED BY LAW, SUCH WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY EXPRESS OR IMPLIED WARRANTY OF MERCHANTABILITY, TITLE, NONINFRINGEMENT OR FITNESS FOR A PARTICULAR PURPOSE.

        10.  LIMITATION OF LIABILITY. NOTWITHSTANDING ANYTHING TO THE CONTRARY IN THIS AGREEMENT, UNDER NO CIRCUMSTANCES SHALL MRP BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY OR SPECIAL DAMAGES, ARISING FROM, RELATED TO OR CAUSED, DIRECTLY OR INDIRECTLY, WHETHER FORESEEABLE OR NOT, BY THE EQUIPMENT AND/OR THE SERVICES, THE USE OR INABILITY TO USE THE EQUIPMENT, THE RESULTS GENERATED FROM THE EQUIPMENT AND/OR THE SERVICES, THIS AGREEMENT, ANY OTHER ACT OR OMISSION OF MRP, OR BASED UPON ANY OTHER LEGAL THEORY. IN NO EVENT SHALL MRP BE LIABLE FOR ANY LOSSES OF REVENUE, USE, BUSINESS OPPORTUNITY, PROFIT, SAVINGS OR ANY OTHER DAMAGES DUE TO ANY CAUSE WHATSOEVER, EVEN IF MRP OR ITS AGENTS HAS BEEN ADVISED OF THE POSSIBILITY THEREOF. THE FOREGOING IS A SEPARATE, ESSENTIAL TERM OF THIS AGREEMENT, AND SHALL BE EFFECTIVE UPON THE FAILURE OF ANY REMEDY, EXCLUSIVE OR NOT. IN NO EVENT WILL MRP’S TOTAL LIABILITY UNDER THIS AGREEMENT EXCEED THE PURCHASE PRICE ACTUALLY PAID TO MRP BY BUYER FOR THE EQUIPMENT AND/OR THE SERVICES GIVING RISE TO THE CLAIM FOR WHICH DAMAGES ARE BEING SOUGHT. NO SUIT OR ACTION MAY BE BROUGHT BY BUYER, ITS SHAREHOLDERS, DIRECTORS, MANAGERS, EMPLOYEES OR AGENTS FOR ANY BREACH OF THIS AGREEMENT MORE THAN ONE (1) YEAR AFTER THE ACCRUAL OF SUCH CAUSE OF ACTION. IT IS AGREED THAT MRP’S LIABILITY IS SO LIMITED. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, BUYER ASSUMES ALL RISK AND LIABILITY FOR THE RESULTS OBTAINED BY THE USE OF ANY EQUIPMENT IN THE PRACTICE OF ANY PROCESS, WHETHER IN TERMS OF OPERATING COSTS, GENERAL EFFECTIVENESS, SUCCESS OR FAILURE, AND REGARDLESS OF ANY ORAL OR WRITTEN STATEMENTS MADE BY MRP, BY WAY OF TECHNICAL ADVICE OR OTHERWISE, RELATED TO THE USE OF THE EQUIPMENT.

        11.  BUYER’S REPRESENTATIONS AND WARRANTIES. Buyer represents and warrants to MRP that: (a) Buyer is duly organized, validly existing, and in good standing in the jurisdiction of Buyer’s formation; (b) Buyer is duly qualified to do business and is in good standing in every jurisdiction in which such qualification is required; (c) Buyer has the full right, power, and authority to enter into this Agreement and to perform Buyer’s obligations under this Agreement; (d) the execution of this Agreement by the person whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of Buyer; (e) when executed and delivered by each of MRP and Buyer, this Agreement will constitute the legal, valid and binding obligation of Buyer, enforceable against Buyer in accordance with its terms; (f) Buyer is in compliance with all applicable laws relating to this Agreement, the Equipment and the operation of Buyer’s business; (g) Buyer is not insolvent and is paying all of its debts as they become due; and (h) all financial information that Buyer has provided to MRP is true and accurate and fairly represents Buyer’s financial condition.

        12. PROPRIETARY RIGHTS.

(a) Ownership. No sale shall be construed as granting to Buyer any license or other right in, or to, any of MRP’s (i) patents; (ii) trademarks; (iii) internet domain names, whether or not trademarks, registered by any authorized private registrar or governmental authority, web addresses, web pages, websites and URLs; (iv) works of authorship, expressions, designs and design registrations, whether or not copyrightable, including copyrights and copyrightable works, software and firmware, technical data, data files, and databases and other specifications and documentation; (v) trade secrets; (vi) environmental or other testing applicable to the Equipment and/or the Services; and (vii) industrial and other intellectual property rights, and all rights, interests, and protections that are associated with, equivalent or similar to, or required for the exercise of, any of the foregoing, however arising, in each case whether registered or unregistered and including all registrations and applications for, and renewals or extensions of, such rights or forms of protection pursuant to the laws of any jurisdiction throughout in any part of the world (collectively, the “Intellectual Property Rights”).

(b) Prohibited Acts. Buyer shall not (i) take any action that might interfere with any of MRP’s rights in or to Intellectual Property Rights, including MRP’s ownership or exercise thereof; (ii) challenge any right, title, or interest of MRP in or to the Intellectual Property Rights; (iii) make any claim or take any action adverse to MRP’s ownership of the Intellectual Property Rights; (iv) register or apply for registrations, anywhere in the world, for MRP’s trademarks or any other trademark that is similar to MRP’s trademarks or that incorporates MRP’s trademarks in whole or in confusingly similar part; (v) use any mark, anywhere that is confusingly

similar to MRP’s trademarks in whole or in confusingly similar part; (vi) engage in any action that tends to disparage, dilute the value of or reflect negatively on the Equipment and/or the Services or any of MRP’s trademarks; (vii) misappropriate any of MRP’s trademarks for use as a domain name without prior written consent from MRP; or (viii) alter, obscure or remove any of MRP’s trademarks, or trademark or copyright notices or any other proprietary rights notices placed on the

Equipment, marketing materials or other materials that MRP may provide.

        13.  CONFIDENTIAL INFORMATION. Without the prior written consent of MRP,Buyer, directly or indirectly, shall not disclose (and will direct its directors, shareholders, employees and agents not to disclose) any Confidential Information. The term “Confidential Information” means any information of or relating to MRP or the Equipment and/or the Services not generally known to the public (other than as a result of disclosure in violation of this Agreement) in spoken, printed, electronic or any other form or medium, including, but not limited to, business processes, practices, methods, policies, plans, publications, documents, research, operations, services, strategies, techniques, agreements, contracts, transactions, potential transactions, know-how, trade secrets, databases, manuals, records, supplier information, financial information, accounting information, legal information, marketing information, pricing information, payroll information, personnel information, and supplier lists.

        14.  NON-SOLICITATION. Buyer agrees not to solicit or hire any personnel of MRP involved with the delivery of the Services during the provision of such Services and for twelve (12) months after the completion of such Services; provided, however, that Buyer may hire individuals employed by MRP who, without other solicitation, respond to advertisements or solicitations aimed at the general public.

        15.  EQUITABLE REMEDIES. Buyer acknowledges and agrees that (a) a breach or threatened breach by Buyer of any of its obligations under Sections 13 or 14 would give rise to irreparable harm to MRP for which monetary damages would not be an adequate remedy and (b) in the event of a breach or a threatened breach by Buyer of any such obligations, MRP shall, in addition to any and all other rights and remedies that may be available to MRP at law, at equity, or otherwise in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance, and any other relief that may be available from a court of competent jurisdiction, without any requirement to post a bond or other security, and without any requirement to prove actual damages or that monetary damages will not afford an adequate remedy. Buyer agrees that Buyer will not oppose or otherwise challenge the appropriateness of equitable relief or the entry by a court of competent jurisdiction of an order granting equitable relief, in either case, consistent with the terms of this Section 15.

        16.  INDEMNIFICATION. Buyer agrees to indemnify, defend and hold harmless MRP and its directors, shareholders, employees and agents (collectively, “MRP Indemnitees”) against any liability, damage, loss or expense incurred by or imposed in connection with any claims, suits, actions, demands or judgments arising out of (a) any breach or non-fulfillment of any representation, warranty or covenant set forth in this Agreement by Buyer or its directors, managers, employees or agents (collectively, “Buyer’s Agents”); (b) any negligent act or omission or willful misconduct of Buyer or Buyer’s Agents in connection with this Agreement; (c) any bodily injury, death of any person or damage to real or tangible personal property caused by Buyer or Buyer’s Agents, including the use of unauthorized parts in or service of the Equipment; (d) any failure by Buyer or Buyer’s Agents to comply with any applicable laws; (e) any fraud or other intentional acts by Buyer or Buyer’s Agents; and (f) the use or operation of the Equipment, including, without limitation, any medical and/or surgical procedures performed by Buyer, and any of Buyer’s Agents, using the Equipment unless said damages are determined by a court of competence jurisdiction to be solely by the gross negligence of MRP or solely as result of a breach by MRP of the limited warranties contained herein.

        17.  DEFAULTS; REMEDIES. Notwithstanding anything herein to the contrary, should Buyer fail to pay for the order or any other amount, in whole or in part, when due or perform its other obligations under this Agreement or as otherwise mutually agreed in writing between Buyer and MRP (each, a “Default”), then MRP may take any and all actions available under law or equity to collect said amounts with a ten (10) day prior written notice, including, but not limited to, enforcing its security interest, accelerating the payment of and declaring immediately due and payable any unpaid balance of the order, referral to outside collection agencies and/or commencement of legal action. MRP’s rights shall be cumulative, and it shall not be required to have attempted to realize upon to the Equipment before taking any other collection actions. MRP may require that Buyer assemble and return any or all of the Equipment to MRP and, in the event Buyer fails to return such Equipment peaceably, enter upon the premises where such Equipment is located, with or without legal process, and repossess such Equipment. Upon a Default, Buyer agrees to pay upon MRP’s demand: (i) all costs and expenses incurred by MRP or its assignee in connection with the enforcement of any remedies, including all expenses incurred in connection with the return, sale, release or other disposition of the Equipment, including attorneys’ fees and other costs incurred by MRP or its assignee in enforcing or defending its rights and remedies under this Agreement and any other written agreement between Buyer and MRP.

        18.  COMPLIANCE WITH LAWS. Buyer shall (a) carry out the transactions contemplated by this sale and deal with the Equipment in conformity with all applicable laws, rules and regulations of all government authorities, including, without limitation, export laws, (b) obtain all permits and licenses required in connection with the purchase, shipment, installation or use of the Equipment, and (c) be solely responsible to fully understand and comply with laws, rules and regulations. Any information provided is as a convenience only.

        19.  FURTHER ASSURANCES. Upon MRP’s reasonable request, Buyer shall, at its sole cost and expense, execute and deliver all such further documents and instruments, and take all such further acts, necessary to give full effect to this Agreement.

        20.  ASSIGNMENT; SUCCESSORS AND ASSIGNS. Buyer cannot delegate any duties nor assign any rights or claims under this Agreement without MRP’s prior written consent, and any such attempt or assignment shall be void. In the event that Buyer finances its acquisition of any Equipment with a third party, Buyer may direct MRP to transfer title of such Equipment to such third-party financing company, with all remaining terms and conditions of this Agreement remaining in full force and effect. This Agreement is binding on and inures to the benefit of the parties to this Agreement and their respective permitted successors and permitted assigns.

        21.  NO THIRD-PARTY BENEFICIARIES. Subject to Section 16, this Agreement benefits solely the parties to this Agreement and their respective permitted successors and assigns, and nothing in this Agreement, express or implied, confers on any other person any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

        22.  GOVERNING LAW; VENUE. The application of the UN Convention on Contracts for the International Sale of Goods is expressly excluded. The parties agree that any and all claims, demands, disagreements, controversies or disputes arising out of or relating to this Agreement and any agreement or document delivered in connection herewith (collectively, “Claims”) shall be governed by and construed in accordance with the laws of the State of Utah and adjudicated exclusively in the state and federal courts located in or nearest to Summit County, Utah, which courts shall have the sole and exclusive jurisdiction and venue for adjudication of all Claims. The parties hereby agree upon, consent and stipulate to the jurisdiction and venue of the aforementioned courts for the adjudication of all Claims, to the exclusion of all other courts, forums and venues whatsoever.

        23.  NON-DISPARAGEMENT. Buyer shall not disparage MRP or MRP’s trademarks, websites, products or services, or display any such items in a derogatory or negative manner on any website or in any public forum or press release.

        24.  NOTICES. Any notice, demand, or communication required, permitted or desired to be given hereunder shall be deemed effectively given when personally delivered, when sent by electronic means, when received by overnight courier, or when mailed by prepaid, certified or registered mail, return receipt requested, addressed to the other party at its address set forth on the Quote or to such other address that the receiving party may designate from time to time in accordance with this Section 25.

        25.  PUBLIC ANNOUNCEMENTS. Unless otherwise stated herein, neither party shall issue a press release or otherwise advertise, make a public statement or disclose to any third-party information pertaining to the relationship arising under this Agreement, the existence or terms of this Agreement, the underlying transactions between MRP and Buyer or agent for Buyer or refer to the other party in relation to this Agreement without the other party’s prior written approval.

        26.  ENTIRE AGREEMENT; ADDITIONAL OR INCONSISTENT TERMS. Subject to Section 32, this Agreement constitutes the sole and entire agreement between the parties hereto relating to the subject matter hereof, and any unincorporated representation, affirmation of fact, course of prior dealings, promise or condition in connection therewith, or usage of the trade, shall not be binding on either party. Terms and conditions set forth which differ from, conflict with or are not included in this Agreement shall not be part of any agreement between MRP and Buyer unless both parties specifically accept such terms and conditions in writing.

        27.  WAIVER. No waiver under this Agreement is effective unless it is in writing and signed by the party waiving its right. Any waiver authorized on one occasion is effective only in that instance and only for the purpose stated and does not operate as a waiver on any future occasion. None of the following constitutes a waiver or estoppel of any right, remedy, power, privilege or condition arising from this Agreement: any failure or delay in exercising any right, remedy, power or privilege or in enforcing any condition under this Agreement; or any act, omission or course of dealing between the parties.

        28.  SURVIVAL. Subject to the limitations and other provisions of this Agreement, the representations and warranties of Buyer contained herein shall survive the expiration or earlier termination of this Agreement for a period of twelve (12) months after such expiration o termination and (b) this Section 29 and Sections 10, 12, 13, 14, 15, 16, 17, 21, 22, 23, 24, 26, and 32 of this Agreement, as well as any other provision that, in order to give proper effect to its intent, should survive such expiration or termination, shall survive the expiration or earlier termination of this Agreement. All other provisions of this Agreement shall not survive the expiration or earlier termination of this Agreement.

        29.  RELATIONSHIP OF PARTIES. Nothing in this Agreement creates any agency, joint venture, partnership or other form of joint enterprise, employment or fiduciary relationship between the parties. Neither party has any express or implied right or authority to assume or create any obligations on behalf of or in the name of the other party or to bind the other party to any contract, agreement or undertaking with any third party.

        30.  HEADINGS. The headings in this Agreement are for reference only and do not affect the interpretation of this Agreement.

        31.  ORDER OF PRECEDENCE. In the event of conflict between the Quote, a written agreement by MRP, and these Terms, the order of priority shall be: (1) the written

agreement by MRP, if only if executed by an MRP Officer, (2) the Quote and (3) these Terms, and only to the extent of the direct conflict. Notwithstanding the foregoing, MRP shall not be bound by, and specifically objects to, any terms, conditions or other provisions, both written and oral, which are different from, in addition to or inconsistent with the provisions of this Agreement which are set forth in any purchase order, receipt, acceptance, confirmation, correspondence or otherwise of, or by, Buyer. Fulfillment of Buyer’s order shall not constitute acceptance of any of Buyer’s terms and conditions and does not serve to modify or amend the terms and conditions contained herein.

        32.  SEVERABILITY. If any part of this Agreement is held to be void, illegal or unenforceable, then it shall be deemed to be severed from this Agreement and the remaining provisions shall continue in full force and effect; provided, however, that if any fundamental term or provision of this Agreement is held to be void, illegal or unenforceable, the remainder of this Agreement shall be unenforceable. Upon a determination that any term or provision is void, illegal or unenforceable, the parties shall negotiate in good faith to modify this Agreement to effect the original intent of the parties as closely as possible in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.